Argon preconditioning enhances postischaemic cardiac functional recovery following cardioplegic arrest and global cold ischaemia.

Attila Kiss,Huaqing Shu,Ouafa Hamza,David Santer,Eva Verena Tretter,Shanglong Yao,Klaus Markstaller,Seth Hallström,Bruno K Podesser,Klaus Ulrich Klein
DOI: https://doi.org/10.1093/ejcts/ezy104
IF: 4.534
2018-01-01
European Journal of Cardio-Thoracic Surgery
Abstract:OBJECTIVES: Previous studies demonstrated that preconditioning with argon gas provided a marked reduction in inflammation and apoptosis and increased myocardial contractility in the setting of acute myocardial ischaemia-reperfusion (IR). There is substantial evidence that myocardial IR injury following cardioplegic arrest is associated with the enhancement of apoptosis and inflammation, which is considered to play a role in cardiac functional impairment. Therefore, the present study was designed to clarify whether preconditioning with argon gas enhances recovery of cardiac function following cardioplegic arrest. METHODS: Sprague-Dawley rats were anaesthetized and ventilated and allocated to (i) the control group (control IR, n = 10) and (ii) the in vivo group (argon IR), which received 3 cycles of argon (50% argon, 21% oxygen and 29% nitrogen, n = 10) administered for 5 min interspersed with 5 min of a gas mixture (79% nitrogen and 21% oxygen). The hearts were excised and then evaluated in an erythrocyteperfused isolated working heart system. Cold ischaemia (4 degrees C) for 60 min was induced by histidine-tryptophan-ketoglutarate cardioplegia, followed by 40 min of reperfusion. Cardiac functional parameters were assessed. In left ventricular tissue samples, the expressions of extracellular-regulated kinase (ERK1/2), AKT serine/threonine kinase (Akt), jun N-terminal kinase (JNK), endothelial nitric oxide synthase (eNOS) and HMGB1: high-mobility group box 1 (HMGB1) protein were assessed by western blot, and high-energy phosphates were evaluated by high-performance liquid chromatography. RESULTS: At the end of reperfusion, the rats preconditioned with argon showed significantly enhanced recovery of cardiac output (101 +/- 6% vs 87 +/- 11%; P < 0.01), stroke volume (94 +/- 4% vs 80 +/- 11%; P = 0.001), external heart work (100 +/- 6% vs 81 +/- 13%; P < 0.001) and coronary flow (90 +/- 13% vs 125 +/- 21%; P < 0.01) compared with the control IR group. These results were accompanied by a significant increase in the levels of myocardial phosphocreatine (23.71 +/- 2.07 mu mol/g protein vs the control IR group, 13.50 +/- 4.75; P = 0.001) and maintained adenosine triphosphate levels (13.62 +/- 1.89 mu mol/g protein vs control IR group adenosine triphosphate: 10.08 +/- 1.94 mu mol/g; P = 0.017). Additionally, preconditioning with argon markedly reduced the activation of JNK (0.11 +/- 0.01 vs 0.25 +/- 0.03; P = 0.005) and the expression of HMGB1 protein (0.52 +/- 0.04 vs 1.5 +/- 0.10; P < 0.001) following reperfusion. CONCLUSIONS: Preconditioning with argon enhanced cardiac functional recovery in rat hearts arrested with histidine-tryptophan-ketoglutarate cardioplegia, thereby representing a potential novel cardioprotective approach in cardiac surgery.
What problem does this paper attempt to address?